Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9d72c1e1c4602fdce8d7c413d03de79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fca6426e50f5a2fa20556ab3f33b548 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
filingDate |
1998-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2000-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec6fa9daa33fc7360e170e6511343eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8682243d917024079114f90bf6837d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_503977b9a8495053945ec430653a8bb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6853fab1e3c5fd7c4e03171f853f6611 |
publicationDate |
2000-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2160075-C2 |
titleOfInvention |
Method for treating the cases of recurrent hemophthalmia edematous hemorrhagic forms of diabetic retinopathy |
abstract |
FIELD: medicine. SUBSTANCE: method involves injecting deoxygenized perfluororganic compound into the vitreous body cavity. The perfluororganic compound deoxygenation is carried out immediately before administration by letting pure nitrogen bubble through it during 5.0 min. EFFECT: enhanced effectiveness of treatment course; reduced risk of traumatic complications. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2521832-C2 |
priorityDate |
1998-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |